Carcinoma, Nonsquamous Non-small-cell Lung
1 clinical trials · Condition
◉ Watch Carcinoma, Nonsquamous Non-small-cell Lung
| Record | Firm | Date |
|---|---|---|
| Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006) (NCT03976323) | Merck Sharp & Dohme LLC | 2019-06-28 |
Track Carcinoma, Nonsquamous Non-small-cell Lung automatically
Every clearance here is in the API, with alerts when new ones post.